Live feed
Filing
SC 13D
SC 13D0001144204-16-141978·PLx Pharma Inc.
Schedule 13D ownership disclosure
DIPEXIUM PHARMACEUTICALS INC
Security class unavailable · CUSIP: 25456J104
Event date: 2016-12-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 39.6300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-141978
- Form type
- SC 13D
- Filer
- PLx Pharma Inc.
- CIK
- CIK 1497504
- Filed
- Jan 03, 2017
- Reporting period
- Dec 22, 2016
- Description
- Schedule 13D beneficial ownership